Compounds and methods for modulating smn2
US-2026085313-A1 · Mar 26, 2026 · US
This page is not indexed by search engines while we improve data quality.
Rigo Frank patents
Rigo Frank is listed as an inventor on 160 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Rigo Frank |
| Total patents | 160 |
| First publication | Jan 22, 2015 |
| Latest publication | Mar 26, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Compounds and methods for modulating GFAP
US-12502402-B2 · Dec 23, 2025 · US
Antisense Compounds Targeted to CLN3 and Uses Thereof
US-2025354147-A1 · Nov 20, 2025 · US
Conjugated Antisense Compounds and Their Use
US-2025333741-A1 · Oct 30, 2025 · US
Methods for Reducing Ataxin-2 Expression
US-2025304970-A1 · Oct 2, 2025 · US
Compounds and Methods for Modulating UBE3A-ATS
US-2025283081-A1 · Sep 11, 2025 · US
Compounds and methods for modulating scn2a
US-2025270556-A1 · Aug 28, 2025 · US
Compounds and methods for reducing dmpk expression
US-2025177433-A1 · Jun 5, 2025 · US
Compounds and methods for modulating smn2
US-2025179493-A1 · Jun 5, 2025 · US
Conjugated antisense compounds and their use
US-12275940-B2 · Apr 15, 2025 · US
Recent patents
Latest publications not already listed above.
Methods for reducing Ataxin-2 expression
US-12188020-B2 · Jan 7, 2025 · US
Compounds and Methods for Reducing ATXN2 Expression
US-2024401039-A1 · Dec 5, 2024 · US
Compounds and methods for modulating scn1a expression
US-2024360449-A1 · Oct 31, 2024 · US
Compounds and Methods for Reducing DMPK Expression
US-2024335556-A1 · Oct 10, 2024 · US
Compounds and methods for reducing dux4 expression
US-2024336915-A1 · Oct 10, 2024 · US
Compounds and Methods for Modulating Splicing of Pre-MRNA
US-2024287513-A1 · Aug 29, 2024 · US
Compounds and Methods for Modulating GFAP
US-2024285669-A1 · Aug 29, 2024 · US
Conjugated antisense compounds and their use
US-2024279664-A1 · Aug 22, 2024 · US
Compositions and methods for modulation of smn2 splicing in a subject
US-2024238326-A1 · Jul 18, 2024 · US
Compositions for Modulating C9ORF72 Expression
US-2024200067-A1 · Jun 20, 2024 · US
Compositions and methods for detection of SMN protein in a subject and treatment of a subject
US-12013403-B2 · Jun 18, 2024 · US
Methods for modulating fmr1 expression
US-2024175021-A1 · May 30, 2024 · US
Compounds and methods for modulating scn2a
US-2024102012-A1 · Mar 28, 2024 · US
Compounds and methods for reducing ATXN2 expression
US-11926825-B2 · Mar 12, 2024 · US
Compounds and methods for modulating scn2a
US-2024026353-A1 · Jan 25, 2024 · US
Oligomeric compounds for reducing DMPK expression
US-11833221-B2 · Dec 5, 2023 · US
Conjugated oligonucleotides and uses thereof
US-2023338555-A1 · Oct 26, 2023 · US
Compounds and methods for modulating GFAP
US-11786546-B2 · Oct 17, 2023 · US
Methods for treating Alzheimer's disease
US-11781135-B2 · Oct 10, 2023 · US
Compounds and methods for the modulation of amyloid-β precursor protein
US-11732260-B2 · Aug 22, 2023 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Ionis Pharmaceuticals Inc | 132 |
| Cold Spring Harbor Laboratory | 18 |
| Isis Pharmaceuticals Inc | 16 |
| Biogen Ma Inc | 15 |
| Univ Rosalind Franklin Medicine & Science | 8 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12N15/113 | 148 |
| C12N2310/11 | 144 |
| C12N2310/315 | 138 |
| C12N2310/3341 | 111 |
| C12N2310/321 | 108 |